Latest Breaking News On - Idania caballero - Page 1 : comparemela.com

Cuba and Russia seal agreements in the field of biotechnology

Moscow, Dec 7 (Prensa Latina) Representatives of the state-owned group BioCubaFarma and the company Labiofam signed a memorandum of understanding with the Russian joint stock company Phitovit for cooperation in the biotechnological and pharmaceutical fields.

Idania caballeroAlejandro gonzMoscow health fairIndustries of the caribbean islandGroup of biotechnologicalHealth fairPharmaceutical industries

Cuba: Soberana 02, Plus vaccines receive annual award in Belarus (+Photos)

Minsk, Oct 9 (Prensa Latina) Cuban Covid-19 vaccines Soberana 02 and Soberana Plus have been awarded on Friday the Grand Prize of the international business event Leader of the Year in Belarus for their contribution to global combat against the pandemic.

Belarus generalIdania caballeroNational centerEurasian unionIndustries group biocubafarmaChildhood vaccination campaignFinlay institute of vaccinesPrensa latinaCuban biotechnologicalPharmaceutical industries groupFinlay instituteMolecular immunologySoberna plus

BioCubaFarma and Moscow State University consolidate their ties (+ Photos)

Moscow, May 17 (Prensa Latina) The representation of the business group BioCubaFarma in Russia and the Faculty of Physics of Moscow State University signed today a memorandum of cooperation for the development of medical devices and teaching exchange.

Sankt peterburgCiudad de la habanaNikolay sysoevIdania caballeroAdolfo castilloPrensa latinaMoscow state university

THE FULL STORY OF CUBA S COVID-19 VACCINES – Times Caribbean Online

THE FULL STORY OF CUBA’S COVID-19 VACCINES Posted on April 23, 2021 in Cuba, International // 0 Comments Some 200 COVID-19 vaccines are being developed worldwide, and 23 candidates have advanced to phase III clinical trials (as of 25 March 2021). Though no other Latin American country has developed a vaccine of its own, two of the 23 now in phase III trials are Cuban: Soberana 02 and Abdala. And Cuba also has three other vaccine candidates in earlier stage trials: Soberana 01, Soberana Plus, and Mambisa. So how has Cuba managed to develop five COVID-19 vaccines in such a short time? Cuba’s biotech sector is unique. It is entirely state-owned and free of private interests, with innovation channelled to meet public health needs and no profit-seeking in the domestic market. Dozens of research and development institutions collaborate, sharing resources and knowledge instead of competing, which facilitates a fast track from research and innovation to trials and application.

United statesUnited kingdomOxford astrazenecaPichia pastorisSinovac butantanMarlene ramBharat biotecIdania caballeroCentre for molecular immunologyFinlay instituteCentre for genetic engineeringNational biopreparations centreLatin americanSoberana plusBritish medical journalMolecular immunology

Cuba s five COVID-19 vaccines: the full story on Soberana 01/02/Plus, Abdala, and Mambisa

Cuba s five COVID-19 vaccines: the full story on Soberana 01/02/Plus, Abdala, and Mambisa
lse.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.ac.uk Daily Mail and Mail on Sunday newspapers.

South africaSantiago de cubaUnited statesUnited kingdomRepublic ofCiudad de la habanaPort au princeHelen yaffeMarlene ramBharat biotecValia rodrOxford astrazenecaPichia pastorisSinovac butantanGerardo guillIdania caballero